Callan Family Office’s Corpay CPAY Stock Holding History

Callan Family Office’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827K	Sell	2,482 -45	-2%	-$14.9K	0.02%	654
2026 Q1	$735K	Buy	2,527 +116	+5%	+$37.2K	0.02%	640
2025 Q4	$726K	Buy	2,411 +1,532	+174%	+$445K	0.02%	651
2025 Q3	$253K	Buy	879 +258	+42%	+$82.2K	0.01%	755
2025 Q2	$206K	Buy	+621	New	+$203K	0.01%	886

Other funds holding CPAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

Callan Family Office's CPAY Position: Q2 2026 in Review

Callan Family Office reduced its Corpay (CPAY) stake by 1.8% in Q2 2026, selling an estimated $14.9K and leaving 2,482 shares worth $827K. The position accounts for 0.02% of the portfolio, ranked #654.

Callan Family Office first reported a position in CPAY in Q2 2025 and has held it in 5 quarters since. 735 funds tracked by Wall St. Rank hold CPAY as of Q2 2026.

Callan Family Office held 2,482 shares of Corpay worth $827K as of Q2 2026.
Callan Family Office sold 45 Corpay shares in Q2 2026, an estimated $14.9K.
Corpay made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #654 holding.
Callan Family Office first reported a position in Corpay in Q2 2025 and has held it in 5 quarters since.
735 funds tracked by Wall St. Rank held Corpay as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.